SOURCE: Unipathic Medicine

Unipathic Medicine

July 22, 2015 14:27 ET

Unipathic Medicine: Affordable Care Act Upheld; Potentially Dumbing Down Cancer and Chronic Lyme Disease Treatment

SCOTTSDALE, AZ--(Marketwired - July 22, 2015) - The Affordable Care Act has been recently making headlines after being upheld by the Supreme Court, but Unipathic Medicine is urging patients not to be fooled by the promise of insurance coverage for everyone, which ultimately limits the treatment options that patients can receive and creates less personalized healthcare. According to CNN, as a result of the Affordable Care Act, insurers have narrowed the networks of doctors and hospitals that can be accessed, making for longer wait times and a lower standard of care. The healthcare system has also struggled with offering the latest and most effective treatments mainly because insurance prefers to cut costs, taking the focus away from the patient and placing a larger emphasis on profits. Better steps need to be implemented to make sure cancer and chronic disease sufferers get the personalized treatments that they need and deserve, and it isn’t the Affordable Care Act.

Insurance and the Affordable Care Act limit a cancer patient to standard chemotherapy, surgery or radiation; or run of the mill antibiotics for a chronic Lyme disease patient. Both of these options are not enough for patients struggling with complex cancers or chronic Lyme disease, and can even be dangerous when not personalized. Unipathic Medicine has found that when it comes to cancer and chronic disease treatment, many times patients respond best to personalized integrative care in a customized treatment protocol tailored to their specific needs. A possible alternative to insurance and a largely unexplored method of coverage is called health share, which allows patients the ability to choose their own doctor and treatments. This method works by collectively paying into a common fund and reallocating the funds when needed to members or patients.

To fully understand insurance (and its downfalls) it is important to understand standard of care. Standard of care establishes guidelines for how physicians treat patients. It means x disease is treated with y medication. This happens because of insurance reimbursement contracts and the political involvement of different medical associations. Because of this, patients can easily get stuck in this non-personalized system. A better way to get patients well again, however, is through the personalization factor, which is the ability to choose the treatment(s) that will work best for a patient’s unique expression of disease. This could include access to biomarker technology and genetically targeted chemotherapy for cancer patients or biofilm removal for Lyme disease patients. This should be directed by the physician and not the insurance companies or political medical associations that have a major conflict of interest here.

A flooded system of inadequate care, AKA the Affordable Care Act, is not the right path for American patients. Instead, specialization, precision targeting, and the best medical technology from around the world, in our opinion, is the better way forward.

Image Available: http://www.marketwire.com/library/MwGo/2015/7/22/11G048406/Images/unipathic_capital-1432098766582.jpg

Contact Information

  • For more information about Unipathic Medicine or additional resources for doctors and patients, contact:
    info@unipathicmedicine.org